Xiaoxiao Cheng

Xiaoxiao Cheng

Auto-generated profile, based on publicly available information

Xiaoxiao Cheng

Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in Science Immunology
Verified
Journal Article
Closed access
TZTianxiang Zhang
Tianxiang Zhang
WYWeiwei Yu
Weiwei Yu
XCXiaoxiao Cheng
Xiaoxiao Cheng
JYJacky T. Yeung
Jacky T. Yeung
VAViviana Ahumada
Viviana Ahumada
LCLieping Chen
Lieping Chen
T cells are often absent from human cancer tissues during both spontaneously induced immunity and therapeutic immunotherapy, even in the presence of a functional T cell–recruiting chemokine system, suggesting the existence of T cell exclusion mechanisms that impair infiltration. Using a genome-wide in vitro screening platform, we identified a role for phospholipase A2 group 10 (PLA2G10) protein in T cell exclusion. PLA2G10 up-regulation is widespread in human cancers and is associated with poor T cell infiltration in tumor tissues. PLA2G10 overexpression in immunogenic mouse tumors excluded T cells from infiltration, resulting in resistance to anti–PD-1 immunotherapy. PLA2G10 can hydrolyze phospholipids into small lipid metabolites, thus inhibiting chemokine-mediated T cell mobility. Ablation of PLA2G10’s enzymatic activity enhanced T cell infiltration and sensitized PLA2G10-overexpressing tumors to immunotherapies. Our study implicates a role for PLA2G10 in T cell exclusion from tumors and suggests a potential target for cancer immunotherapy.